Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Makiko Nishiyama
Efficiency, Safety, and Patient Preference of Switching From Dorzolamide 1%/Timolol 0.5% to Brinzolamide 1%/Timolol 0.5% While Maintaining the Prostaglandin F2α Analog
Clinical Ophthalmology
Ophthalmology
Related publications
Patient Perspectives When Switching From Cosopt® (Dorzolamide-Timolol) to Azarga™ (Brinzolamide-Timolol) for Glaucoma Requiring Multiple Drug Therapy
Clinical Ophthalmology
Ophthalmology
Addition of a Fixed Combination of Brinzolamide 1%/Timolol 0.5% to Prostaglandin Monotherapy in Patients With Glaucoma or Ocular Hypertension
Clinical Ophthalmology
Ophthalmology
Efficacy and Safety of Switching From Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy
Open Ophthalmology Journal
Ophthalmology
Additive Intraocular Pressure-Lowering Effect of Dorzolamide 1%/Timolol 0.5% Fixed Combination on Prostaglandin Monotherapy in Patients With Normal Tension Glaucoma
Clinical Ophthalmology
Ophthalmology
Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy
Journal of Ophthalmology
Ophthalmology
Efficacy and Safety of a Switch to Latanoprost 0.005% + Timolol Maleate 0.5% Fixed Combination Eyedrops From Latanoprost 0.005% Monotherapy
Clinical Ophthalmology
Ophthalmology
Treatment of Glaucoma With the Fixed Combination of Latanoprost 0.005% and Timolol 0.5%
European Ophthalmic Review
Managing Refractory Glaucoma With a Fixed Combination of Bimatoprost (0.03%) and Timolol (0.5%)
Clinical Ophthalmology
Ophthalmology
A Study of the Effects of Topical Timolol 0.5% and Bimatoprost 0.03% on the Ocular Surface
Journal of Evidence Based Medicine and Healthcare
